Compare GRANULES INDIA with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs INDOCO REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA INDOCO REMEDIES GRANULES INDIA/
INDOCO REMEDIES
 
P/E (TTM) x 16.5 30.1 55.0% View Chart
P/BV x 3.7 5.2 71.0% View Chart
Dividend Yield % 0.5 0.3 135.6%  

Financials

 GRANULES INDIA   INDOCO REMEDIES
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
INDOCO REMEDIES
Mar-21
GRANULES INDIA/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs438336 130.5%   
Low Rs138190 72.7%   
Sales per share (Unadj.) Rs130.7134.7 97.0%  
Earnings per share (Unadj.) Rs22.210.1 219.7%  
Cash flow per share (Unadj.) Rs28.318.0 156.9%  
Dividends per share (Unadj.) Rs1.501.50 100.0%  
Avg Dividend yield %0.50.6 91.2%  
Book value per share (Unadj.) Rs86.883.4 104.1%  
Shares outstanding (eoy) m247.6792.15 268.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.22.0 113.0%   
Avg P/E ratio x13.026.0 49.9%  
P/CF ratio (eoy) x10.214.6 69.8%  
Price / Book Value ratio x3.33.1 105.3%  
Dividend payout %6.814.9 45.5%   
Avg Mkt Cap Rs m71,33724,215 294.6%   
No. of employees `000NANA-   
Total wages/salary Rs m3,2432,740 118.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m32,37512,415 260.8%  
Other income Rs m26991 296.8%   
Total revenues Rs m32,64412,506 261.0%   
Gross profit Rs m8,5522,183 391.7%  
Depreciation Rs m1,515731 207.1%   
Interest Rs m263223 118.1%   
Profit before tax Rs m7,0441,320 533.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,549390 397.7%   
Profit after tax Rs m5,495930 590.5%  
Gross profit margin %26.417.6 150.2%  
Effective tax rate %22.029.5 74.5%   
Net profit margin %17.07.5 226.5%  
BALANCE SHEET DATA
Current assets Rs m19,9706,225 320.8%   
Current liabilities Rs m11,7314,069 288.3%   
Net working cap to sales %25.417.4 146.5%  
Current ratio x1.71.5 111.3%  
Inventory Days Days1622 75.3%  
Debtors Days Days863687 125.5%  
Net fixed assets Rs m17,1577,117 241.1%   
Share capital Rs m248184 134.4%   
"Free" reserves Rs m21,2627,506 283.3%   
Net worth Rs m21,5107,690 279.7%   
Long term debt Rs m3,411969 351.9%   
Total assets Rs m37,12713,343 278.3%  
Interest coverage x27.86.9 401.2%   
Debt to equity ratio x0.20.1 125.8%  
Sales to assets ratio x0.90.9 93.7%   
Return on assets %15.58.6 179.4%  
Return on equity %25.512.1 211.1%  
Return on capital %29.317.8 164.6%  
Exports to sales %81.943.7 187.5%   
Imports to sales %26.810.2 262.5%   
Exports (fob) Rs m26,5285,426 488.9%   
Imports (cif) Rs m8,6911,270 684.5%   
Fx inflow Rs m26,5285,426 488.9%   
Fx outflow Rs m8,6911,270 684.5%   
Net fx Rs m17,8374,157 429.1%   
CASH FLOW
From Operations Rs m4,325822 526.0%  
From Investments Rs m-2,771-667 415.5%  
From Financial Activity Rs m-2,993-299 1,002.0%  
Net Cashflow Rs m-1,441-143 1,004.6%  

Share Holding

Indian Promoters % 41.6 58.7 70.9%  
Foreign collaborators % 0.4 0.0 -  
Indian inst/Mut Fund % 25.7 19.4 132.6%  
FIIs % 21.4 1.6 1,319.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 41.3 140.5%  
Shareholders   216,385 37,279 580.4%  
Pledged promoter(s) holding % 7.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Plunges 656 Points, Nifty Ends Below 18,000; Oil & Gas, Metal Stocks Outperform(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

INDOCO REMEDIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 27, 2021 | Updated on Oct 27, 2021

Here's an analysis of the annual report of INDOCO REMEDIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


Jan 19, 2022 03:35 PM

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA 8-QTR ANALYSIS

COMPARE GRANULES INDIA WITH

MARKET STATS